GeoPolitics Pulse

The Heartbeat of World events

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab …

by ·

ELAHERE is the first and only folate receptor alpha (FRɑ)-directed antibody drug conjugate (ADC) medicine approved in the European Union (EU), as well …Read More

Related posts:

  1. European Commission Approves AbbVie’s ELAHERE For Platinum-Resistant Ovarian … – Nasdaq
  2. European Commission Approves Mirvetuximab Soravtansine for FRα+ Platinum-Resistant …
  3. European Commission Approves Mirvetuximab Soravtansine for FRα+ Platinum-Resistant …
  4. Calliditas partner STADA receives European Commission decision for full approval of … – KXAN
  5. TEPKINLY® (epcoritamab) Receives Second European Commission Approval for … – Business Wire